Ur Rehman M, Chuntakaruk H, Amphan S, Suroengrit A, Hengphasatporn K, Shigeta Y
ACS Bio Med Chem Au. 2024; 4(5):242-256.
PMID: 39431267
PMC: 11487539.
DOI: 10.1021/acsbiomedchemau.4c00040.
Adokoh C, Boadu A, Asiamah I, Agoni C
Front Chem. 2024; 12:1424019.
PMID: 39119520
PMC: 11306053.
DOI: 10.3389/fchem.2024.1424019.
Ghosh A, Sharma A, Ghazi S
Tetrahedron Lett. 2024; 140.
PMID: 38586565
PMC: 10994151.
DOI: 10.1016/j.tetlet.2024.155013.
Ghosh A, Mishevich J, Kovela S, Shaktah R, Ghosh A, Johnson M
Eur J Med Chem. 2023; 255:115385.
PMID: 37150084
PMC: 10759558.
DOI: 10.1016/j.ejmech.2023.115385.
Spielvogel E, Lee S, Zhou S, Lockbaum G, Henes M, Sondgeroth A
Elife. 2023; 12.
PMID: 36920025
PMC: 10065791.
DOI: 10.7554/eLife.80328.
Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studies.
Ghosh A, Shahabi D, Kipfmiller M, Ghosh A, Johnson M, Wang Y
Bioorg Med Chem Lett. 2023; 83:129168.
PMID: 36738797
PMC: 10061991.
DOI: 10.1016/j.bmcl.2023.129168.
Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants.
Ma L, Wen J, Dong B, Zhou J, Hu S, Wang J
Int J Mol Sci. 2022; 23(22).
PMID: 36430656
PMC: 9697080.
DOI: 10.3390/ijms232214178.
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance.
Ghosh A, Weber I, Mitsuya H
Chem Commun (Camb). 2022; 58(84):11762-11782.
PMID: 36200462
PMC: 10942761.
DOI: 10.1039/d2cc04541a.
Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates.
Otvos S, Kappe C
Green Chem. 2021; 23(17):6117-6138.
PMID: 34671222
PMC: 8447942.
DOI: 10.1039/d1gc01615f.
Nickel Catalyzed Vinylidene Insertions into O-H Bonds.
Kang H, Uyeda C
ACS Catal. 2021; 11(1):193-198.
PMID: 33996195
PMC: 8115312.
DOI: 10.1021/acscatal.0c04713.
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
Matthew A, Leidner F, Lockbaum G, Henes M, Zephyr J, Hou S
Chem Rev. 2021; 121(6):3238-3270.
PMID: 33410674
PMC: 8126998.
DOI: 10.1021/acs.chemrev.0c00648.
The Chiron Approach to (3,3,6)-Hexahydrofuro[2,3-]furan-3-ol, a Key Subunit of HIV-1 Protease Inhibitor Drug, Darunavir.
Ghosh A, Markad S, Robinson W
J Org Chem. 2020; 86(1):1216-1222.
PMID: 33267583
PMC: 7894212.
DOI: 10.1021/acs.joc.0c02396.
Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities.
Ghosh A, Grillo A, Raghavaiah J, Kovela S, Johnson M, Kneller D
ACS Med Chem Lett. 2020; 11(10):1965-1972.
PMID: 33062180
PMC: 7549267.
DOI: 10.1021/acsmedchemlett.9b00670.
Lewis Acid-Catalyzed Vinyl Acetal Rearrangement of 4,5-Dihydro-1,3-dioxepines: Stereoselective Synthesis of and 2,3-Disubstituted Tetrahydrofurans.
Ghosh A, Belcher M
J Org Chem. 2020; 85(16):10399-10412.
PMID: 32806103
PMC: 7898272.
DOI: 10.1021/acs.joc.0c00390.
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
Rusere L, Lockbaum G, Henes M, Lee S, Spielvogel E, Rao D
J Med Chem. 2020; 63(15):8296-8313.
PMID: 32672965
PMC: 7971191.
DOI: 10.1021/acs.jmedchem.0c00529.
Novel HIV-1 Protease Inhibitors with Morpholine as the P2 Ligand to Enhance Activity against DRV-Resistant Variants.
Zhu M, Dou Y, Ma L, Dong B, Zhang F, Zhang G
ACS Med Chem Lett. 2020; 11(6):1196-1204.
PMID: 32551001
PMC: 7294734.
DOI: 10.1021/acsmedchemlett.0c00043.
Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
Ghosh A, Kovela S, Osswald H, Amano M, Aoki M, Agniswamy J
J Med Chem. 2020; 63(9):4867-4879.
PMID: 32348139
PMC: 7425579.
DOI: 10.1021/acs.jmedchem.0c00202.
Application of human lymphoid cells for the evaluation of antivirals against human adenovirus type 19: Zalcitabine has superior activity compared to cidofovir.
Nakagawara K, Hayashi H, Kawaji K, Sasano M, Kodama E
Antivir Chem Chemother. 2020; 28:2040206620921319.
PMID: 32345035
PMC: 7218274.
DOI: 10.1177/2040206620921319.
Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation.
Ghosh A, Williams J, Kovela S, Takayama J, Simpson H, Walters D
Bioorg Med Chem Lett. 2019; 29(18):2565-2570.
PMID: 31416666
PMC: 6711809.
DOI: 10.1016/j.bmcl.2019.08.006.
A Photochemical Route to Optically Active Hexahydro-4-furopyranol, a High-Affinity P2 Ligand for HIV-1 Protease Inhibitors.
Ghosh A, Robinson W
J Org Chem. 2019; 84(15):9801-9805.
PMID: 31310117
PMC: 7048240.
DOI: 10.1021/acs.joc.9b01361.
